Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

Condition:   Pulmonary Emphysema in Alpha-1 PI Deficiency
Interventions:   Biological: Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP);   Other: 0.9% Sodium Chloride for Injection, USP
Sponsor:   Grifols Therapeutics Inc.
Recruiting – verified August 2016
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
clinicaltrials

Source: clinicaltrials

Deixe uma resposta

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *

doze − 4 =